International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

Abroad (travel likely)Recruiting

Conditions

Antiphospholipid Syndrome · Thrombosis · Anticoagulants Causing Adverse Effects in Therapeutic Use

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stéphane Zuily, Nancy, France
Contact: Study coordinator (Stéphane Zuily, MD, PhD) · s.zuily@chru-nancy.fr · +33383157354
Contact: Principal Investigator (Virginie Dufrost, MD, MSc)
Denis Wahl, MD, PhD (Sub-investigator)
Stéphane Zuily, MD, PhD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Antiphospholipid Syndrome (APS) · Venous Thrombosis (Disorder) · Thrombophilia

Abroad (travel likely)Recruiting

Madrid, Spain · Madrid, Spain

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

Antiphospholipid Syndrome · Arterial Thrombosis

Abroad (travel likely)Recruiting

Buenos Aires, Argentina · Córdoba, Argentina

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Rheumatoid Arthritis (RA) · Juvenile Idiopathic Arthritis (JIA) · Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE4

São Paulo, Brazil · São Paulo, Brazil

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Antiphospholipid Syndrome (APS)

Abroad (travel likely)RecruitingPHASE2

Athens, Greece